Skip to main content
. 2016 Jun 15;11(6):e0157612. doi: 10.1371/journal.pone.0157612

Fig 2. Ultraviolet–Visible spectroscopy.

Fig 2

(A) CMC@AgNPs at (a) 0.5%, (b) 1%, (c) 1.5%, and (d) 2% (B) CMC. (II) SA@AgNPs at (a) 0.5%, (b) 1%, (c) 1.5%, and (d) 2% SA. Arrow indicates direction of spectral changes.